A Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy-Reference-Cited by-全球学者库

A Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy

Published:2007-02 Issue:3 Volume:128 Page:589-600
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Hilfiker-Kleiner Denise,Kaminski Karol,Podewski Edith,Bonda Tomasz,Schaefer Arnd,Sliwa Karen,Forster Olaf,Quint Anja,Landmesser Ulf,Doerries Carola,Luchtefeld Maren,Poli Valeria,Schneider Michael D.,Balligand Jean-Luc,Desjardins Fanny,Ansari Aftab,Struman Ingrid,Nguyen Ngoc Q.N.,Zschemisch Nils H.,Klein Gunnar,Heusch Gerd,Schulz Rainer,Hilfiker Andres,Drexler Helmut

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference37 articles.

1. VEGF differentially activates STAT3 in microvascular endothelial cells;Bartoli;FASEB J.,2003

2. Inhibition of oncogene STAT3 phosphorylation by a prolactin antagonist, hPRL-G129R, in T-47D human breast cancer cells;Cataldo;Int. J. Oncol.,2000

3. Molecular determinants of responses to myocardial ischemia/reperfusion injury: focus on hypoxia-inducible and heat shock factors;Chi;Cardiovasc. Res.,2004

4. Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis;Corbacho;J. Endocrinol.,2002

5. Molecular and functional signature of heart hypertrophy during pregnancy;Eghbali;Circ. Res.,2005

Cited by 701 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers in Peripartum Cardiomyopathy—What We Know and What Is Still to Be Found;Biomolecules;2024-01-12

2. Peripartum Cardiomyopathy;New England Journal of Medicine;2024-01-11

3. The exploration of the pathogenesis and causative relationship of hypertrophic cardiomyopathy mediated by STAT3 through bioinformatics and Mendelian randomization;2024-01-05

4. The global landscape of peripartum cardiomyopathy: Morbidity, mortality, recovery and inequity;European Journal of Heart Failure;2023-12-12

5. Vasoinhibin’s Apoptotic, Inflammatory, and Fibrinolytic Actions Are in a Motif Different From Its Antiangiogenic HGR Motif;Endocrinology;2023-12-06